nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP2C19—prostate cancer	0.216	0.611	CbGaD
Ramelteon—CYP3A4—prostate cancer	0.137	0.389	CbGaD
Ramelteon—CYP2C19—Nilutamide—prostate cancer	0.0449	0.0987	CbGbCtD
Ramelteon—CYP2C19—Bicalutamide—prostate cancer	0.0449	0.0987	CbGbCtD
Ramelteon—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0413	0.0909	CbGbCtD
Ramelteon—CYP2C19—Flutamide—prostate cancer	0.0372	0.0818	CbGbCtD
Ramelteon—CYP1A2—Flutamide—prostate cancer	0.0343	0.0755	CbGbCtD
Ramelteon—CYP1A2—Estrone—prostate cancer	0.0248	0.0546	CbGbCtD
Ramelteon—CYP3A4—Bicalutamide—prostate cancer	0.0217	0.0477	CbGbCtD
Ramelteon—CYP3A4—Estramustine—prostate cancer	0.0202	0.0444	CbGbCtD
Ramelteon—CYP3A4—Abiraterone—prostate cancer	0.018	0.0396	CbGbCtD
Ramelteon—CYP3A4—Flutamide—prostate cancer	0.018	0.0396	CbGbCtD
Ramelteon—CYP1A2—Conjugated Estrogens—prostate cancer	0.0162	0.0357	CbGbCtD
Ramelteon—CYP2C19—Estradiol—prostate cancer	0.0154	0.034	CbGbCtD
Ramelteon—CYP1A2—Estradiol—prostate cancer	0.0142	0.0314	CbGbCtD
Ramelteon—CYP3A4—Cabazitaxel—prostate cancer	0.0133	0.0293	CbGbCtD
Ramelteon—CYP2C19—Prednisone—prostate cancer	0.0133	0.0292	CbGbCtD
Ramelteon—CYP3A4—Estrone—prostate cancer	0.013	0.0286	CbGbCtD
Ramelteon—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0116	0.0255	CbGbCtD
Ramelteon—CYP1A2—Etoposide—prostate cancer	0.0093	0.0205	CbGbCtD
Ramelteon—CYP3A4—Conjugated Estrogens—prostate cancer	0.0085	0.0187	CbGbCtD
Ramelteon—CYP3A4—Mitoxantrone—prostate cancer	0.00772	0.017	CbGbCtD
Ramelteon—CYP3A4—Estradiol—prostate cancer	0.00746	0.0164	CbGbCtD
Ramelteon—CYP3A4—Prednisone—prostate cancer	0.00642	0.0141	CbGbCtD
Ramelteon—CYP3A4—Etoposide—prostate cancer	0.00487	0.0107	CbGbCtD
Ramelteon—CYP3A4—Docetaxel—prostate cancer	0.00446	0.00981	CbGbCtD
Ramelteon—CYP3A4—Doxorubicin—prostate cancer	0.00332	0.00731	CbGbCtD
Ramelteon—Mental disability—Degarelix—prostate cancer	0.00151	0.0175	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Abiraterone—prostate cancer	0.00124	0.0144	CcSEcCtD
Ramelteon—Depression—Estramustine—prostate cancer	0.00123	0.0142	CcSEcCtD
Ramelteon—Influenza—Nilutamide—prostate cancer	0.00122	0.0142	CcSEcCtD
Ramelteon—Depression—Estrone—prostate cancer	0.00117	0.0136	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Nilutamide—prostate cancer	0.00114	0.0132	CcSEcCtD
Ramelteon—Depression—Nilutamide—prostate cancer	0.00109	0.0126	CcSEcCtD
Ramelteon—Thinking abnormal—Goserelin—prostate cancer	0.00107	0.0124	CcSEcCtD
Ramelteon—Influenza—Cabazitaxel—prostate cancer	0.00103	0.0119	CcSEcCtD
Ramelteon—Depression—Estradiol valerate/Dienogest—prostate cancer	0.00102	0.0118	CcSEcCtD
Ramelteon—Depression—Degarelix—prostate cancer	0.000971	0.0113	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Cabazitaxel—prostate cancer	0.000956	0.0111	CcSEcCtD
Ramelteon—Influenza—Bicalutamide—prostate cancer	0.000883	0.0102	CcSEcCtD
Ramelteon—Mental disability—Goserelin—prostate cancer	0.000849	0.00984	CcSEcCtD
Ramelteon—Myalgia—Abiraterone—prostate cancer	0.000794	0.0092	CcSEcCtD
Ramelteon—Depression—Bicalutamide—prostate cancer	0.000785	0.00909	CcSEcCtD
Ramelteon—Arthralgia—Estrone—prostate cancer	0.000781	0.00905	CcSEcCtD
Ramelteon—Anaphylactic shock—Estrone—prostate cancer	0.000749	0.00867	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Conjugated Estrogens—prostate cancer	0.000727	0.00842	CcSEcCtD
Ramelteon—Insomnia—Estramustine—prostate cancer	0.000709	0.00821	CcSEcCtD
Ramelteon—Dysgeusia—Cabazitaxel—prostate cancer	0.000702	0.00813	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Ethinyl Estradiol—prostate cancer	0.000693	0.00803	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Abiraterone—prostate cancer	0.000693	0.00803	CcSEcCtD
Ramelteon—Insomnia—Abiraterone—prostate cancer	0.000688	0.00797	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Estrone—prostate cancer	0.000682	0.0079	CcSEcCtD
Ramelteon—Depression—Ethinyl Estradiol—prostate cancer	0.000663	0.00768	CcSEcCtD
Ramelteon—Fatigue—Abiraterone—prostate cancer	0.000656	0.0076	CcSEcCtD
Ramelteon—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000653	0.00757	CcSEcCtD
Ramelteon—Arthralgia—Degarelix—prostate cancer	0.000648	0.00751	CcSEcCtD
Ramelteon—Insomnia—Nilutamide—prostate cancer	0.000629	0.00729	CcSEcCtD
Ramelteon—Insomnia—Flutamide—prostate cancer	0.000626	0.00725	CcSEcCtD
Ramelteon—Anaphylactic shock—Degarelix—prostate cancer	0.000621	0.0072	CcSEcCtD
Ramelteon—Somnolence—Flutamide—prostate cancer	0.000615	0.00713	CcSEcCtD
Ramelteon—Influenza—Goserelin—prostate cancer	0.000614	0.00711	CcSEcCtD
Ramelteon—Arthralgia—Cabazitaxel—prostate cancer	0.00061	0.00707	CcSEcCtD
Ramelteon—Myalgia—Cabazitaxel—prostate cancer	0.00061	0.00707	CcSEcCtD
Ramelteon—Influenza—Conjugated Estrogens—prostate cancer	0.000608	0.00705	CcSEcCtD
Ramelteon—Fatigue—Flutamide—prostate cancer	0.000597	0.00691	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Estradiol—prostate cancer	0.000582	0.00674	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Goserelin—prostate cancer	0.000571	0.00661	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Degarelix—prostate cancer	0.000566	0.00656	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Conjugated Estrogens—prostate cancer	0.000565	0.00655	CcSEcCtD
Ramelteon—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.000563	0.00653	CcSEcCtD
Ramelteon—Insomnia—Degarelix—prostate cancer	0.000562	0.00651	CcSEcCtD
Ramelteon—Asthenia—Abiraterone—prostate cancer	0.000546	0.00633	CcSEcCtD
Ramelteon—Depression—Goserelin—prostate cancer	0.000546	0.00632	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.000542	0.00628	CcSEcCtD
Ramelteon—Depression—Conjugated Estrogens—prostate cancer	0.000541	0.00626	CcSEcCtD
Ramelteon—Diarrhoea—Estramustine—prostate cancer	0.000536	0.00621	CcSEcCtD
Ramelteon—Fatigue—Degarelix—prostate cancer	0.000535	0.0062	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Cabazitaxel—prostate cancer	0.000533	0.00618	CcSEcCtD
Ramelteon—Myalgia—Bicalutamide—prostate cancer	0.000524	0.00607	CcSEcCtD
Ramelteon—Diarrhoea—Abiraterone—prostate cancer	0.000521	0.00603	CcSEcCtD
Ramelteon—Fatigue—Cabazitaxel—prostate cancer	0.000504	0.00584	CcSEcCtD
Ramelteon—Asthenia—Nilutamide—prostate cancer	0.000499	0.00578	CcSEcCtD
Ramelteon—Asthenia—Flutamide—prostate cancer	0.000497	0.00575	CcSEcCtD
Ramelteon—Dizziness—Estrone—prostate cancer	0.000495	0.00574	CcSEcCtD
Ramelteon—Headache—Estramustine—prostate cancer	0.000491	0.00569	CcSEcCtD
Ramelteon—Influenza—Estradiol—prostate cancer	0.000487	0.00564	CcSEcCtD
Ramelteon—Diarrhoea—Nilutamide—prostate cancer	0.000476	0.00551	CcSEcCtD
Ramelteon—Diarrhoea—Flutamide—prostate cancer	0.000474	0.00549	CcSEcCtD
Ramelteon—Headache—Estrone—prostate cancer	0.000469	0.00543	CcSEcCtD
Ramelteon—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000469	0.00543	CcSEcCtD
Ramelteon—Nausea—Estramustine—prostate cancer	0.000465	0.00539	CcSEcCtD
Ramelteon—Dizziness—Nilutamide—prostate cancer	0.00046	0.00533	CcSEcCtD
Ramelteon—Dizziness—Flutamide—prostate cancer	0.000458	0.0053	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.000457	0.0053	CcSEcCtD
Ramelteon—Insomnia—Bicalutamide—prostate cancer	0.000454	0.00526	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Estradiol—prostate cancer	0.000452	0.00524	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Etoposide—prostate cancer	0.000451	0.00522	CcSEcCtD
Ramelteon—Somnolence—Bicalutamide—prostate cancer	0.000446	0.00517	CcSEcCtD
Ramelteon—Asthenia—Degarelix—prostate cancer	0.000446	0.00516	CcSEcCtD
Ramelteon—Nausea—Estrone—prostate cancer	0.000445	0.00515	CcSEcCtD
Ramelteon—Headache—Nilutamide—prostate cancer	0.000436	0.00505	CcSEcCtD
Ramelteon—Headache—Flutamide—prostate cancer	0.000434	0.00502	CcSEcCtD
Ramelteon—Depression—Estradiol—prostate cancer	0.000433	0.00501	CcSEcCtD
Ramelteon—Fatigue—Bicalutamide—prostate cancer	0.000433	0.00501	CcSEcCtD
Ramelteon—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000432	0.00501	CcSEcCtD
Ramelteon—Diarrhoea—Degarelix—prostate cancer	0.000425	0.00492	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Mitoxantrone—prostate cancer	0.000421	0.00488	CcSEcCtD
Ramelteon—Mental disability—Capecitabine—prostate cancer	0.00042	0.00486	CcSEcCtD
Ramelteon—Asthenia—Cabazitaxel—prostate cancer	0.00042	0.00486	CcSEcCtD
Ramelteon—Dysgeusia—Conjugated Estrogens—prostate cancer	0.000415	0.00481	CcSEcCtD
Ramelteon—Nausea—Nilutamide—prostate cancer	0.000413	0.00478	CcSEcCtD
Ramelteon—Nausea—Flutamide—prostate cancer	0.000411	0.00476	CcSEcCtD
Ramelteon—Dizziness—Degarelix—prostate cancer	0.000411	0.00476	CcSEcCtD
Ramelteon—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000409	0.00474	CcSEcCtD
Ramelteon—Diarrhoea—Cabazitaxel—prostate cancer	0.0004	0.00464	CcSEcCtD
Ramelteon—Headache—Degarelix—prostate cancer	0.000389	0.00451	CcSEcCtD
Ramelteon—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000388	0.0045	CcSEcCtD
Ramelteon—Dizziness—Cabazitaxel—prostate cancer	0.000387	0.00448	CcSEcCtD
Ramelteon—Nausea—Degarelix—prostate cancer	0.000369	0.00427	CcSEcCtD
Ramelteon—Thinking abnormal—Epirubicin—prostate cancer	0.000368	0.00427	CcSEcCtD
Ramelteon—Headache—Cabazitaxel—prostate cancer	0.000367	0.00425	CcSEcCtD
Ramelteon—Fatigue—Ethinyl Estradiol—prostate cancer	0.000366	0.00424	CcSEcCtD
Ramelteon—Arthralgia—Goserelin—prostate cancer	0.000364	0.00422	CcSEcCtD
Ramelteon—Myalgia—Goserelin—prostate cancer	0.000364	0.00422	CcSEcCtD
Ramelteon—Arthralgia—Conjugated Estrogens—prostate cancer	0.000361	0.00418	CcSEcCtD
Ramelteon—Myalgia—Conjugated Estrogens—prostate cancer	0.000361	0.00418	CcSEcCtD
Ramelteon—Asthenia—Bicalutamide—prostate cancer	0.00036	0.00417	CcSEcCtD
Ramelteon—Anaphylactic shock—Goserelin—prostate cancer	0.000349	0.00405	CcSEcCtD
Ramelteon—Nausea—Cabazitaxel—prostate cancer	0.000348	0.00403	CcSEcCtD
Ramelteon—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000346	0.00401	CcSEcCtD
Ramelteon—Diarrhoea—Bicalutamide—prostate cancer	0.000343	0.00398	CcSEcCtD
Ramelteon—Thinking abnormal—Doxorubicin—prostate cancer	0.000341	0.00395	CcSEcCtD
Ramelteon—Dysgeusia—Estradiol—prostate cancer	0.000332	0.00385	CcSEcCtD
Ramelteon—Dizziness—Bicalutamide—prostate cancer	0.000332	0.00385	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000318	0.00369	CcSEcCtD
Ramelteon—Insomnia—Goserelin—prostate cancer	0.000316	0.00366	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000315	0.00365	CcSEcCtD
Ramelteon—Headache—Bicalutamide—prostate cancer	0.000314	0.00364	CcSEcCtD
Ramelteon—Insomnia—Conjugated Estrogens—prostate cancer	0.000313	0.00362	CcSEcCtD
Ramelteon—Somnolence—Goserelin—prostate cancer	0.00031	0.0036	CcSEcCtD
Ramelteon—Dysgeusia—Mitoxantrone—prostate cancer	0.000309	0.00359	CcSEcCtD
Ramelteon—Somnolence—Conjugated Estrogens—prostate cancer	0.000307	0.00356	CcSEcCtD
Ramelteon—Asthenia—Ethinyl Estradiol—prostate cancer	0.000304	0.00353	CcSEcCtD
Ramelteon—Influenza—Capecitabine—prostate cancer	0.000304	0.00352	CcSEcCtD
Ramelteon—Fatigue—Goserelin—prostate cancer	0.000301	0.00349	CcSEcCtD
Ramelteon—Fatigue—Conjugated Estrogens—prostate cancer	0.000298	0.00345	CcSEcCtD
Ramelteon—Nausea—Bicalutamide—prostate cancer	0.000298	0.00345	CcSEcCtD
Ramelteon—Mental disability—Epirubicin—prostate cancer	0.000292	0.00339	CcSEcCtD
Ramelteon—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00029	0.00336	CcSEcCtD
Ramelteon—Arthralgia—Estradiol—prostate cancer	0.000289	0.00335	CcSEcCtD
Ramelteon—Myalgia—Estradiol—prostate cancer	0.000289	0.00335	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000282	0.00327	CcSEcCtD
Ramelteon—Dizziness—Ethinyl Estradiol—prostate cancer	0.000281	0.00325	CcSEcCtD
Ramelteon—Anaphylactic shock—Estradiol—prostate cancer	0.000277	0.00321	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—prostate cancer	0.000271	0.00314	CcSEcCtD
Ramelteon—Depression—Capecitabine—prostate cancer	0.00027	0.00313	CcSEcCtD
Ramelteon—Arthralgia—Mitoxantrone—prostate cancer	0.000269	0.00312	CcSEcCtD
Ramelteon—Myalgia—Mitoxantrone—prostate cancer	0.000269	0.00312	CcSEcCtD
Ramelteon—Headache—Ethinyl Estradiol—prostate cancer	0.000266	0.00308	CcSEcCtD
Ramelteon—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000258	0.00299	CcSEcCtD
Ramelteon—Dysgeusia—Etoposide—prostate cancer	0.000257	0.00298	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000253	0.00293	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000252	0.00292	CcSEcCtD
Ramelteon—Nausea—Ethinyl Estradiol—prostate cancer	0.000252	0.00292	CcSEcCtD
Ramelteon—Asthenia—Goserelin—prostate cancer	0.00025	0.0029	CcSEcCtD
Ramelteon—Insomnia—Estradiol—prostate cancer	0.00025	0.0029	CcSEcCtD
Ramelteon—Asthenia—Conjugated Estrogens—prostate cancer	0.000248	0.00287	CcSEcCtD
Ramelteon—Somnolence—Estradiol—prostate cancer	0.000246	0.00285	CcSEcCtD
Ramelteon—Depression—Prednisone—prostate cancer	0.00024	0.00279	CcSEcCtD
Ramelteon—Diarrhoea—Goserelin—prostate cancer	0.000239	0.00277	CcSEcCtD
Ramelteon—Fatigue—Estradiol—prostate cancer	0.000239	0.00276	CcSEcCtD
Ramelteon—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000237	0.00274	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000235	0.00272	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000234	0.00271	CcSEcCtD
Ramelteon—Dizziness—Goserelin—prostate cancer	0.000231	0.00268	CcSEcCtD
Ramelteon—Somnolence—Mitoxantrone—prostate cancer	0.000229	0.00266	CcSEcCtD
Ramelteon—Dizziness—Conjugated Estrogens—prostate cancer	0.000229	0.00265	CcSEcCtD
Ramelteon—Fatigue—Mitoxantrone—prostate cancer	0.000222	0.00258	CcSEcCtD
Ramelteon—Headache—Goserelin—prostate cancer	0.000219	0.00253	CcSEcCtD
Ramelteon—Headache—Conjugated Estrogens—prostate cancer	0.000217	0.00251	CcSEcCtD
Ramelteon—Anaphylactic shock—Etoposide—prostate cancer	0.000215	0.00249	CcSEcCtD
Ramelteon—Dysgeusia—Docetaxel—prostate cancer	0.000214	0.00248	CcSEcCtD
Ramelteon—Influenza—Epirubicin—prostate cancer	0.000211	0.00245	CcSEcCtD
Ramelteon—Nausea—Goserelin—prostate cancer	0.000207	0.0024	CcSEcCtD
Ramelteon—Dysgeusia—Capecitabine—prostate cancer	0.000207	0.0024	CcSEcCtD
Ramelteon—Nausea—Conjugated Estrogens—prostate cancer	0.000205	0.00238	CcSEcCtD
Ramelteon—Asthenia—Estradiol—prostate cancer	0.000199	0.0023	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000197	0.00228	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—prostate cancer	0.000196	0.00227	CcSEcCtD
Ramelteon—Somnolence—Etoposide—prostate cancer	0.000191	0.00221	CcSEcCtD
Ramelteon—Diarrhoea—Estradiol—prostate cancer	0.000189	0.00219	CcSEcCtD
Ramelteon—Myalgia—Docetaxel—prostate cancer	0.000186	0.00215	CcSEcCtD
Ramelteon—Arthralgia—Docetaxel—prostate cancer	0.000186	0.00215	CcSEcCtD
Ramelteon—Asthenia—Mitoxantrone—prostate cancer	0.000185	0.00214	CcSEcCtD
Ramelteon—Fatigue—Etoposide—prostate cancer	0.000185	0.00214	CcSEcCtD
Ramelteon—Dizziness—Estradiol—prostate cancer	0.000183	0.00212	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000182	0.00211	CcSEcCtD
Ramelteon—Myalgia—Capecitabine—prostate cancer	0.00018	0.00209	CcSEcCtD
Ramelteon—Arthralgia—Capecitabine—prostate cancer	0.00018	0.00209	CcSEcCtD
Ramelteon—Anaphylactic shock—Docetaxel—prostate cancer	0.000178	0.00207	CcSEcCtD
Ramelteon—Diarrhoea—Mitoxantrone—prostate cancer	0.000176	0.00204	CcSEcCtD
Ramelteon—Headache—Estradiol—prostate cancer	0.000173	0.00201	CcSEcCtD
Ramelteon—Nausea—Estradiol—prostate cancer	0.000164	0.0019	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000162	0.00188	CcSEcCtD
Ramelteon—Headache—Mitoxantrone—prostate cancer	0.000162	0.00187	CcSEcCtD
Ramelteon—Insomnia—Docetaxel—prostate cancer	0.000161	0.00187	CcSEcCtD
Ramelteon—Myalgia—Prednisone—prostate cancer	0.00016	0.00186	CcSEcCtD
Ramelteon—Arthralgia—Prednisone—prostate cancer	0.00016	0.00186	CcSEcCtD
Ramelteon—Somnolence—Docetaxel—prostate cancer	0.000158	0.00184	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000157	0.00182	CcSEcCtD
Ramelteon—Insomnia—Capecitabine—prostate cancer	0.000156	0.00181	CcSEcCtD
Ramelteon—Asthenia—Etoposide—prostate cancer	0.000154	0.00178	CcSEcCtD
Ramelteon—Anaphylactic shock—Prednisone—prostate cancer	0.000154	0.00178	CcSEcCtD
Ramelteon—Fatigue—Docetaxel—prostate cancer	0.000154	0.00178	CcSEcCtD
Ramelteon—Nausea—Mitoxantrone—prostate cancer	0.000153	0.00177	CcSEcCtD
Ramelteon—Fatigue—Capecitabine—prostate cancer	0.000149	0.00172	CcSEcCtD
Ramelteon—Diarrhoea—Etoposide—prostate cancer	0.000147	0.0017	CcSEcCtD
Ramelteon—Dysgeusia—Epirubicin—prostate cancer	0.000144	0.00167	CcSEcCtD
Ramelteon—Dizziness—Etoposide—prostate cancer	0.000142	0.00164	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Prednisone—prostate cancer	0.00014	0.00162	CcSEcCtD
Ramelteon—Insomnia—Prednisone—prostate cancer	0.000139	0.00161	CcSEcCtD
Ramelteon—Headache—Etoposide—prostate cancer	0.000134	0.00156	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—prostate cancer	0.000134	0.00155	CcSEcCtD
Ramelteon—Fatigue—Prednisone—prostate cancer	0.000133	0.00154	CcSEcCtD
Ramelteon—Asthenia—Docetaxel—prostate cancer	0.000128	0.00148	CcSEcCtD
Ramelteon—Nausea—Etoposide—prostate cancer	0.000127	0.00148	CcSEcCtD
Ramelteon—Arthralgia—Epirubicin—prostate cancer	0.000125	0.00145	CcSEcCtD
Ramelteon—Myalgia—Epirubicin—prostate cancer	0.000125	0.00145	CcSEcCtD
Ramelteon—Asthenia—Capecitabine—prostate cancer	0.000124	0.00143	CcSEcCtD
Ramelteon—Diarrhoea—Docetaxel—prostate cancer	0.000122	0.00141	CcSEcCtD
Ramelteon—Anaphylactic shock—Epirubicin—prostate cancer	0.00012	0.00139	CcSEcCtD
Ramelteon—Diarrhoea—Capecitabine—prostate cancer	0.000118	0.00137	CcSEcCtD
Ramelteon—Dizziness—Docetaxel—prostate cancer	0.000118	0.00137	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—prostate cancer	0.000116	0.00134	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—prostate cancer	0.000116	0.00134	CcSEcCtD
Ramelteon—Dizziness—Capecitabine—prostate cancer	0.000114	0.00132	CcSEcCtD
Ramelteon—Headache—Docetaxel—prostate cancer	0.000112	0.00129	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—prostate cancer	0.000111	0.00129	CcSEcCtD
Ramelteon—Asthenia—Prednisone—prostate cancer	0.00011	0.00128	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.00011	0.00127	CcSEcCtD
Ramelteon—Insomnia—Epirubicin—prostate cancer	0.000109	0.00126	CcSEcCtD
Ramelteon—Headache—Capecitabine—prostate cancer	0.000108	0.00125	CcSEcCtD
Ramelteon—Somnolence—Epirubicin—prostate cancer	0.000107	0.00124	CcSEcCtD
Ramelteon—Nausea—Docetaxel—prostate cancer	0.000106	0.00123	CcSEcCtD
Ramelteon—Diarrhoea—Prednisone—prostate cancer	0.000105	0.00122	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—prostate cancer	0.000104	0.0012	CcSEcCtD
Ramelteon—Nausea—Capecitabine—prostate cancer	0.000103	0.00119	CcSEcCtD
Ramelteon—Dizziness—Prednisone—prostate cancer	0.000102	0.00118	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000101	0.00117	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—prostate cancer	0.000101	0.00117	CcSEcCtD
Ramelteon—Somnolence—Doxorubicin—prostate cancer	9.89e-05	0.00115	CcSEcCtD
Ramelteon—Headache—Prednisone—prostate cancer	9.63e-05	0.00112	CcSEcCtD
Ramelteon—Fatigue—Doxorubicin—prostate cancer	9.59e-05	0.00111	CcSEcCtD
Ramelteon—Nausea—Prednisone—prostate cancer	9.13e-05	0.00106	CcSEcCtD
Ramelteon—Asthenia—Epirubicin—prostate cancer	8.63e-05	0.001	CcSEcCtD
Ramelteon—Diarrhoea—Epirubicin—prostate cancer	8.23e-05	0.000953	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—prostate cancer	7.98e-05	0.000925	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—prostate cancer	7.95e-05	0.000921	CcSEcCtD
Ramelteon—Diarrhoea—Doxorubicin—prostate cancer	7.61e-05	0.000882	CcSEcCtD
Ramelteon—Headache—Epirubicin—prostate cancer	7.53e-05	0.000873	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—prostate cancer	7.36e-05	0.000852	CcSEcCtD
Ramelteon—Nausea—Epirubicin—prostate cancer	7.14e-05	0.000828	CcSEcCtD
Ramelteon—Headache—Doxorubicin—prostate cancer	6.97e-05	0.000808	CcSEcCtD
Ramelteon—Nausea—Doxorubicin—prostate cancer	6.61e-05	0.000766	CcSEcCtD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	9.25e-06	8.73e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	9.19e-06	8.67e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SULT1E1—prostate cancer	9.16e-06	8.65e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SRD5A1—prostate cancer	9.16e-06	8.65e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TBXAS1—prostate cancer	9.14e-06	8.63e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTA4—prostate cancer	9.14e-06	8.63e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—prostate cancer	9.09e-06	8.58e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—prostate cancer	9.09e-06	8.58e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.94e-06	8.43e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTA2—prostate cancer	8.91e-06	8.41e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSD17B1—prostate cancer	8.9e-06	8.4e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	8.9e-06	8.4e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SULT1A1—prostate cancer	8.8e-06	8.31e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCG5—prostate cancer	8.8e-06	8.31e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	8.77e-06	8.27e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACSL4—prostate cancer	8.74e-06	8.25e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HSD17B3—prostate cancer	8.74e-06	8.25e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	8.64e-06	8.15e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTA1—prostate cancer	8.6e-06	8.11e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NAT2—prostate cancer	8.5e-06	8.02e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTO1—prostate cancer	8.5e-06	8.02e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HSD3B2—prostate cancer	8.5e-06	8.02e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PHGDH—prostate cancer	8.38e-06	7.91e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—UMPS—prostate cancer	8.38e-06	7.91e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ARG2—prostate cancer	8.38e-06	7.91e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CA—prostate cancer	8.35e-06	7.88e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CA—prostate cancer	8.35e-06	7.88e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	8.34e-06	7.87e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—LDHB—prostate cancer	8.22e-06	7.75e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.17e-06	7.71e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—LRP2—prostate cancer	8.15e-06	7.69e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2C18—prostate cancer	8.15e-06	7.69e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PLCB2—prostate cancer	8.15e-06	7.69e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—prostate cancer	8.08e-06	7.63e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—prostate cancer	8.08e-06	7.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP3A5—prostate cancer	8.07e-06	7.61e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—P4HB—prostate cancer	7.99e-06	7.54e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HPGD—prostate cancer	7.93e-06	7.49e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—B4GALT4—prostate cancer	7.93e-06	7.49e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—UCP3—prostate cancer	7.79e-06	7.35e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PDHA1—prostate cancer	7.79e-06	7.35e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA3—prostate cancer	7.79e-06	7.35e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TCN2—prostate cancer	7.79e-06	7.35e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC22A1—prostate cancer	7.78e-06	7.34e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.69e-06	7.25e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SULT2A1—prostate cancer	7.58e-06	7.15e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.46e-06	7.04e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MED12—prostate cancer	7.45e-06	7.03e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HSD3B1—prostate cancer	7.43e-06	7.01e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC22A3—prostate cancer	7.43e-06	7.01e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—prostate cancer	7.4e-06	6.98e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—prostate cancer	7.4e-06	6.98e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GNG5—prostate cancer	7.4e-06	6.98e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.26e-06	6.85e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTAP—prostate cancer	7.26e-06	6.85e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.21e-06	6.8e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TBXAS1—prostate cancer	7.12e-06	6.72e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA4—prostate cancer	7.12e-06	6.72e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA3—prostate cancer	7.12e-06	6.72e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.07e-06	6.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.07e-06	6.67e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7e-06	6.61e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.96e-06	6.57e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA2—prostate cancer	6.94e-06	6.55e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SULT1A1—prostate cancer	6.86e-06	6.47e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCG5—prostate cancer	6.86e-06	6.47e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—prostate cancer	6.82e-06	6.44e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—prostate cancer	6.82e-06	6.44e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HPGDS—prostate cancer	6.8e-06	6.41e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.75e-06	6.37e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACSL4—prostate cancer	6.75e-06	6.37e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA1—prostate cancer	6.7e-06	6.32e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTO1—prostate cancer	6.62e-06	6.25e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HSD3B2—prostate cancer	6.62e-06	6.25e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NAT2—prostate cancer	6.62e-06	6.25e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—prostate cancer	6.59e-06	6.22e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ACHE—prostate cancer	6.59e-06	6.22e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2A6—prostate cancer	6.52e-06	6.15e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.49e-06	6.12e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—UMPS—prostate cancer	6.47e-06	6.1e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PHGDH—prostate cancer	6.47e-06	6.1e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ARG2—prostate cancer	6.47e-06	6.1e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.37e-06	6.01e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.35e-06	5.99e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—LRP2—prostate cancer	6.35e-06	5.99e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PLCB2—prostate cancer	6.35e-06	5.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—LDHB—prostate cancer	6.34e-06	5.98e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKR1C3—prostate cancer	6.34e-06	5.98e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PRKACB—prostate cancer	6.3e-06	5.95e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP17A1—prostate cancer	6.24e-06	5.89e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—P4HB—prostate cancer	6.23e-06	5.88e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.23e-06	5.87e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.15e-06	5.81e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC22A1—prostate cancer	6.06e-06	5.72e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PDHA1—prostate cancer	6.01e-06	5.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA3—prostate cancer	6.01e-06	5.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—UCP3—prostate cancer	6.01e-06	5.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TCN2—prostate cancer	6.01e-06	5.67e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.99e-06	5.65e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA2—prostate cancer	5.95e-06	5.61e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SULT2A1—prostate cancer	5.9e-06	5.57e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MED12—prostate cancer	5.81e-06	5.48e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GNG5—prostate cancer	5.76e-06	5.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.74e-06	5.41e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.74e-06	5.41e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A5—prostate cancer	5.67e-06	5.35e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA3—prostate cancer	5.55e-06	5.24e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2E1—prostate cancer	5.54e-06	5.23e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA4—prostate cancer	5.5e-06	5.19e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.5e-06	5.19e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NQO1—prostate cancer	5.48e-06	5.17e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.45e-06	5.15e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TH—prostate cancer	5.4e-06	5.09e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.36e-06	5.06e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA2—prostate cancer	5.36e-06	5.06e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.34e-06	5.04e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.31e-06	5.02e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HPGDS—prostate cancer	5.3e-06	5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCG5—prostate cancer	5.29e-06	5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.29e-06	5e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.26e-06	4.97e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.25e-06	4.96e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA1—prostate cancer	5.17e-06	4.88e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACHE—prostate cancer	5.14e-06	4.85e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—prostate cancer	5.14e-06	4.85e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTO1—prostate cancer	5.11e-06	4.82e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.11e-06	4.82e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NAT2—prostate cancer	5.11e-06	4.82e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GGT1—prostate cancer	5.09e-06	4.8e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2A6—prostate cancer	5.08e-06	4.79e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.06e-06	4.77e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA1—prostate cancer	5.01e-06	4.73e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.94e-06	4.66e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.94e-06	4.66e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PRKACB—prostate cancer	4.91e-06	4.64e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—LRP2—prostate cancer	4.9e-06	4.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.9e-06	4.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PLCB2—prostate cancer	4.9e-06	4.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.86e-06	4.59e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—P4HB—prostate cancer	4.81e-06	4.54e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.8e-06	4.53e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—RXRA—prostate cancer	4.77e-06	4.5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.68e-06	4.41e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.64e-06	4.37e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA2—prostate cancer	4.63e-06	4.37e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—COMT—prostate cancer	4.59e-06	4.33e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—prostate cancer	4.57e-06	4.31e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.56e-06	4.3e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ITPR1—prostate cancer	4.5e-06	4.24e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MED12—prostate cancer	4.48e-06	4.23e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GNG5—prostate cancer	4.45e-06	4.2e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.42e-06	4.17e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.42e-06	4.17e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.32e-06	4.07e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA3—prostate cancer	4.28e-06	4.04e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NQO1—prostate cancer	4.27e-06	4.03e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMS—prostate cancer	4.25e-06	4.01e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TH—prostate cancer	4.21e-06	3.97e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—prostate cancer	4.2e-06	3.96e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.18e-06	3.94e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.16e-06	3.93e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.14e-06	3.91e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—LPL—prostate cancer	4.12e-06	3.89e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HPGDS—prostate cancer	4.09e-06	3.86e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.06e-06	3.83e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.98e-06	3.76e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACHE—prostate cancer	3.96e-06	3.74e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—prostate cancer	3.96e-06	3.74e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GGT1—prostate cancer	3.96e-06	3.74e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ERCC2—prostate cancer	3.95e-06	3.73e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.92e-06	3.7e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA1—prostate cancer	3.9e-06	3.68e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.85e-06	3.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.81e-06	3.6e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PRKACB—prostate cancer	3.79e-06	3.58e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.75e-06	3.54e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—RXRA—prostate cancer	3.71e-06	3.5e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTHFR—prostate cancer	3.71e-06	3.5e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPARA—prostate cancer	3.64e-06	3.44e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.61e-06	3.41e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—COMT—prostate cancer	3.58e-06	3.38e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA2—prostate cancer	3.58e-06	3.37e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—prostate cancer	3.56e-06	3.36e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ITPR1—prostate cancer	3.5e-06	3.31e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.44e-06	3.25e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CAV1—prostate cancer	3.42e-06	3.23e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.41e-06	3.22e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.33e-06	3.14e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMS—prostate cancer	3.31e-06	3.12e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NQO1—prostate cancer	3.29e-06	3.11e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—prostate cancer	3.27e-06	3.09e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.27e-06	3.09e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TH—prostate cancer	3.25e-06	3.06e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—LPL—prostate cancer	3.21e-06	3.03e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.12e-06	2.94e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.1e-06	2.93e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ERCC2—prostate cancer	3.08e-06	2.9e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GGT1—prostate cancer	3.06e-06	2.89e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA1—prostate cancer	3.01e-06	2.84e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.97e-06	2.8e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—INS—prostate cancer	2.95e-06	2.78e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—prostate cancer	2.89e-06	2.73e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CREBBP—prostate cancer	2.89e-06	2.73e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—RXRA—prostate cancer	2.87e-06	2.7e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARA—prostate cancer	2.84e-06	2.68e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—COMT—prostate cancer	2.76e-06	2.61e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—prostate cancer	2.75e-06	2.59e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.74e-06	2.59e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ITPR1—prostate cancer	2.7e-06	2.55e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CAV1—prostate cancer	2.67e-06	2.52e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NOS3—prostate cancer	2.59e-06	2.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMS—prostate cancer	2.55e-06	2.41e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.55e-06	2.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—prostate cancer	2.52e-06	2.38e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—LPL—prostate cancer	2.48e-06	2.34e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.43e-06	2.29e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.39e-06	2.26e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.39e-06	2.25e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ERCC2—prostate cancer	2.37e-06	2.24e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—prostate cancer	2.37e-06	2.23e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—INS—prostate cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CREBBP—prostate cancer	2.25e-06	2.13e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—prostate cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARA—prostate cancer	2.19e-06	2.07e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—prostate cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CAV1—prostate cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NOS3—prostate cancer	2.02e-06	1.9e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—EP300—prostate cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.87e-06	1.77e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.86e-06	1.76e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—prostate cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—INS—prostate cancer	1.77e-06	1.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CREBBP—prostate cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.65e-06	1.56e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—prostate cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NOS3—prostate cancer	1.56e-06	1.47e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—EP300—prostate cancer	1.53e-06	1.45e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.46e-06	1.37e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.44e-06	1.36e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—prostate cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—prostate cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—prostate cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—EP300—prostate cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—prostate cancer	9.27e-07	8.75e-06	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.76e-07	8.26e-06	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—prostate cancer	7.15e-07	6.75e-06	CbGpPWpGaD
